Paul Ryan joins Board

JANESVILLE, Wis., Aug. 26, 2019 – SHINE Medical Technologies, LLC today announced the appointment of Paul D. Ryan to the company’s board of directors.

Silatronix® awarded $10.1 million Navy ONR contract

MADISON, Wis.–(BUSINESS WIRE)–Silatronix® has been awarded a $10.1 million contract from the U.S. Navy Office of Naval Research (ONR). The contract, entitled “Organosilicon Electrolytes for Safe, High Energy, High-Nickel NMC Li-ion Batteries” will focus on the use of Organosilicon (OS) electrolytes to improve the cycling stability of Li-ion cells using NMC622 and NMC811 cathode materials in combination with various state-of-the-art anode materials. This ONR project leverages Silatronix® substantial expertise in the development of new OS based solvents for Li-ion battery applications, and the Company’s world class, Li-ion battery materials evaluation laboratory and analysis capability.

$15-million DOE/NNSA award for medical isotope

JANESVILLE, Wis., Aug. 9, 2019 – SHINE Medical Technologies LLC today announced it has received a $15-million award from the Department of Energy’s National Nuclear Security Administration (DOE/NNSA). The award was made by the agency as part of its effort to establish a reliable, U.S.-produced supply of molybdenum-99 (Mo-99), the most commonly used medical isotope, without the use of highly enriched uranium.